BEIJING, Dec. 7, 2018 /PRNewswire/ -- Concord Medical
Services Holdings Limited ("Concord Medical" or the "Company")
(NYSE: CCM), a leading cancer hospital operations management
solutions provider and operator of a network of radiotherapy and
diagnostic imaging centers in China, today announced that it will hold its
2018 annual general meeting of shareholders on December 29, 2018, at 10:00 a.m. (Beijing Time). The meeting will be
held at 18/F, Tower A, Global Trade Center, 36 North 3rd Ring Road
East, Dongcheng District, Beijing,
China. The shareholder record date is December 17, 2018. No proposal will be submitted
for shareholder approval at the annual general meeting. Instead,
the annual general meeting will be convened for shareholders who
are entitled to vote to discuss Company affairs with management.
Concord Medical's annual report on Form 20-F filed with the U.S.
Securities and Exchange Commission, containing the Company's
audited financial statements for the financial year ended
December 31, 2017, is available in
the Investor Relations section of the Company's website at
http://ir.ccm.cn. The Form 20-F is also
available on the SEC's website at
http://www.sec.gov.
In October 2018, Bluestone
Holdings Limited ("Bluestone"), a company indirectly wholly owned
by Dr. Zheng Cheng, transferred its
shares in Morgancreek Investment Holdings Limited ("Morgancreek")
(which in turn held shares in Concord Medical) to companies wholly
owned by Mr. Hao Zhou and Ms. Bi Zhang, the spouse of Mr.
Jianyu Yang, respectively. On the
same day, all the Class A Ordinary Shares of Concord Medical held
by Morgancreek were converted into Class B Ordinary Shares of
Concord Medical. Morgancreek transferred 7,500,000 Class B Ordinary
Shares of Concord Medical to Bluestone. Upon completion of these
transactions, Mr. Zhou and Ms. Zhang indirectly hold 30% and 70%
shares of Morgancreek, respectively, and Dr. Cheng holds shares of
Concord Medical through Bluestone. As of the date of this
announcement, Morgancreek holds 38,287,948 Class B Ordinary Shares
and 4,660,976 American Depositary Shares of Concord Medical, each
representing three Class A ordinary shares, and Bluestone holds
7,500,000 Class B Ordinary Shares of Concord Medical. As of the
date of this announcement, the Company has 84,368,529 Class A
Ordinary Shares and 45,787,948 Class B Ordinary Shares issued and
outstanding. Holders of Class A ordinary shares are entitled to one
vote per share, while holders of Class B ordinary shares are
entitled to ten votes per share.
About Concord Medical
Concord Medical Services Holdings Limited is a leading specialty
hospital management solution provider and operator of the largest
network of radiotherapy and diagnostic imaging centers in
China. As of June 30, 2018, the Company operated a network of
30 centers with 21 hospital partners that spanned 21 cities and 14
provinces and administrative regions in China. Under long-term arrangements with
top-tier hospitals in China, the
Company provides radiotherapy and diagnostic imaging equipment and
manages the daily operations of these centers, which are located on
the premises of its hospital partners. The Company also provides
ongoing training to doctors and other medical professionals in its
network of centers to ensure a high level of clinical care for
patients. For more information, please see
http://ir.ccm.cn.
For more information, please contact:
Concord Medical Services
Mr. Edward Zhang (Chinese and
English)
+86 10 5903 6688 (ext. 608)
zhongchen.zhang@ccm.cn
View original
content:http://www.prnewswire.com/news-releases/concord-medical-schedules-2018-annual-meeting-of-shareholders-300761796.html
SOURCE Concord Medical Services Holdings Limited